Federal award
BLOODWORKS
N6264518P2001
Contract
Obligated and Ceiling
- Obligated (net)
- $357,899.00
- Ceiling (potential value, not spending)
- $357,899.00
- Current value
- $357,899.00
- Gross positive obligations
- $500,295.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BLOODWORKS · ZN56PFWUDQK7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- BLOODWORKS · ZN56PFWUDQK7
- Awarding agency
- Department of War · sub-agency 97DH · office HT9406
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- N6264518P2001
- Award type code
- B
- Actions
- 13 · Nov 30, 2017 to Aug 9, 2022
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 9, 2022 | FY2022 | P00012 | M | $0.00 | — |
| Nov 8, 2021 | FY2022 | P00011 | M | $0.00 | — |
| Sep 28, 2021 | FY2021 | P00010 | B | $5,050.00 | — |
| Mar 2, 2021 | FY2021 | P00009 | M | −$73,836.00 | — |
| Nov 25, 2020 | FY2021 | P00008 | G | $72,690.00 | — |
| Sep 15, 2020 | FY2020 | P00007 | D | $30,800.00 | — |
| Jun 8, 2020 | FY2020 | P00006 | C | $8,000.00 | — |
| Apr 22, 2020 | FY2020 | P00005 | D | −$68,560.00 | — |
| Nov 20, 2019 | FY2020 | P00004 | G | $131,100.00 | — |
| Sep 16, 2019 | FY2019 | P00003 | B | $5,945.00 | — |
| Nov 5, 2018 | FY2019 | P00002 | G | $125,155.00 | — |
| Jul 3, 2018 | FY2018 | P00001 | D | $44,400.00 | — |
| Nov 30, 2017 | FY2018 | 0 | — | $77,155.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.